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in the present trial; Table 2 shows the samples received as well
as the technique(s) used by each laboratory. HHT300, HHT400) (Table 4) derived from the parental cell line K562 and selected using increasing concentrations of homoharringtonine (natural anticancer drug), 8 exhibiting vari- 
RT-PCR
able levels of resistance to daunorubicin (DNR) were sent, in RPMI 1640 medium supplemented with 10% fetal calf serum, Each laboratory participating in the trial carried out semito trial participants. In order to avoid any bias in the results, quantitative determination of mdr1 gene expression by RTa code name was attributed to each cell line. Also, either fresh PCR 10-12 by comparing the signal yielded from mdr1 gene cells or preparations of RNA obtained from KB-A1 and KB-3-expression to the signal yielded from either ␤2 microglobulin 1 cell lines 9 were sent from one laboratory (I) to the others for (14 laboratories) or ␤ actin gene expression (laboratory XII) calibration and standardization of the RT-PCR technique.
( Table 2 ). The amplifications were either performed in the same tube or in separate tubes, and semi-quantification was carried out after: (1) coloration of the gel with ethidium bro-
Solid tumors
mide; (2) transfer and hybridization with internal oligonucleotides to the amplified products labelled with 32 P; or (3) 32 P incorporation during PCR. During periods 1 and 2 the laboraSix large malignant (breast: five, ovary: one) tumors, split by a pathologist into 10-12 macroscopically homogeneous fragtories participating in the trial used their own techniques, their own systems of quantification and their own positive and ments (Table 5) , as well as 10 RNA and 10 cDNA samples, prepared as described by Chevillard et al, 10 were sent frozen negative controls. Afterwards, all participants realized a calibrating curve according to the method described by Chevillard to the 14 trial participants. All of the tumors (except tumor No. 6) were surgical resections obtained from previously untreated et al 10 while maintaining their own conditions (MgCl 2 concentrations, specific primers and number of cycles), in order to patients; information concerning the chemosensitivity or chemoresistance of these tumors is not therefore available.
control that RT-PCR assays were done in the exponential range and not in the plateau range, to standardize results and seven-fold resistant as compared to K562) cell lines began to decrease (Table 6 ). Then, all participants (except laboratory to define a common threshold of positivity. Briefly, a standard curve was constructed from yields of RT-PCR reactions using XVII) systematically performed a standard curve and, as shown in Table 6 , gave concordant results. At the beginning of period serial dilutions (1/2 to 1/256) of RNA obtained from the KB-A1 cell line (with a 270-fold mdr1 gene expression) with RNA 6, participants received KB-A1 and KB-3-1 cell lines in order to perform themselves a standard curve from fresh cells. Figure  obtained from the KB-3-1 cell line (with no detectable mdr1 gene expression).
9 Hence, the linearity of all RT-PCR assays 1a and b shows the results obtained by each laboratory: serial dilutions (1 to 1/256) of RNA obtained from the KB-A1 cell line was always controlled, and we were able to estimate the level of mdr1 gene expression in the different samples by setting with RNA obtained from the KB-3-1 cell line (mimicking levels of expression ranging from 270-to one-fold) are shown on the the threshold of positivity above the 1/128 dilution, roughly corresponding to a two-fold level of mdr1 gene expression. left, whereas expanded curves (dilutions ranging from 1/32 to 1/256), corresponding to levels of expression detected in leukemic and breast tumor samples, are presented on the right. Variability of PCR primers, of MgCl 2 concentrations and of the Immunohistochemistry total number of PCR cycles is illustrated by the various mdr1/␤2 microglobulin (or/␤ actin) ratios observed, for a given dilution, Immunohistochemical detection of P-glycoprotein was performed on snap-frozen sections of solid tumors. Since this analyfrom one team to another one (Figure 1a and b) . However, the linearity of the RT-PCR assay for detecting low levels of sis was conducted during period 3, all participants had already gained significant experience from the previous expression is quite reliable in each laboratory (right part of Figure 1a and b) . The threshold of positivity, arbitrarily set on immunocytochemistry assays performed on leukemic samples during periods 1 and 2. Following our meeting of November dilution 1/128 (corresponding to a two-fold level of mdr1 gene expression), is in accordance with the results obtained from cell 1994, we wrote guidelines for fixation and storage of slides. Frozen sections had to be fixed in cold acetone (−20°C) for lines exhibiting low levels of resistance (Table 6 ; period 5). A large prospective study is now needed to determine whether 30-60 s or in 1% paraformaldehyde at room temperature for 10 min, then used immediately or stored at −20°C until used this threshold of positivity is a relevant tool for predicting clinical response in leukemia. before immunodetection using C219, C494 and JSB1 or MRK16 antibodies, respectively.
The incubation time with each antibody, used at 10 g/ml, ranged from 1 h to overnight at room temperature or at 4°C,
and the second antibody was either peroxydase-or alkaline phosphatase-labelled. The threshold of positivity ranged from RT-PCR and immunohistochemical results are shown in 1 to 5% tumor cells exhibiting a staining (depending on each Tables 7 to 12 . Laboratories I and II dealt with the same tumor laboratory), and the intensity of the staining was reported as fragments (RNA and frozen sections were prepared in laboranegative (−), low (+), positive (++) and strongly positive (+++). tory I). Laboratories IV and XI sent their RNA to laboratories V and XII, respectively.
Results and discussion
Tumor No. 1 (Table 7) : RT-PCR or Northern blot: out of
Leukemic samples
eight analyses, two were considered as positive, one as borderline and five as negative. RT-PCR results obtained from leukemic cells are summarized Immunohistochemistry: out of six laboratories, three conin Table 6 . Out of 173 samples sent by overnight express mail, cluded that this tumor was positive and three that it was negaonly four (2.3%) samples were not analyzed due to microbial tive. Overall, no discordance was observed within each labcontamination or cell death. Each laboratory received two to oratory (except laboratory VIII) using different antibodies, and 30 samples. Overall, no significant delay was noted for transthe background observed using peroxidase was higher than mitting the results from each laboratory, and all participants in that using alkaline phosphatase. the trial followed the guidelines of our sequential meetings. In
Heterogeneity of large solid tumors as well as sensitivity and order better to analyze and compare our results, categories specificity of the different techniques may explain these disnamed (−) or (±) were finally scored as negative (−) (no mdr1 cordant results. The discordant RT-PCR results from laboragene expression), whereas categories named (+) and (++) were tories I and II are more surprising since they worked on the scored as positive (+) (significant mdr1 gene expression). For a same RNA. However, the cDNA from laboratory II was posigiven sample, results established by less than 50% of the labtive by RT-PCR when it was analyzed by laboratory I (each oratories participating in the trial were classified as discordant laboratory used different sets of PCR primers). results (positive or negative). During periods 1, 2 and 3, each laboratory handled samples with its own technique, and discordant results ranged from 23 to 31% (Table 6 ). These large discrepancies were first assigned to problems concerning (Table 8) :
RT-PCR or Northern blot: out of eight analyses, six were considered as positive and two as specificity and positioning of the threshold of positivity, but at that time, we did not elaborate upon a clear common strategy.
negative. Immunohistochemistry: out of six laboratories, four conAt the beginning of period 4, only four participants decided to standardize their RT-PCR assays, by means of the technique cluded that this tumor was negative, one that it was positive and one concluded opposite results (laboratory III). No discorused in laboratory I 10 using serial dilutions of RNA from the KB-A1 cell line with RNA from the KB-3-1 cell line, and the dance was noted within each laboratory using the different antibodies, except one (laboratory III), depending on the sysfrequency of discordant results (17%) concerning leukemic samples as well as parental (K562) and resistant (HHT100:
tem of revelation (peroxidase vs alkaline phosphatase).
